Balaji Amines Limited · NSE:BALAMINES

Balaji Amines — Q4 FY2024 Earnings Presentation

47 slides from Balaji Amines's earnings presentation, May 10, 2024

  1. Slide 1: Exchange filing cover letter for Q4FY24 investor presentation

    10th May, 2024 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (

  2. Slide 2: Investor Presentation - May 2024

    Investor Presentation - May 2024

  3. Slide 3: Disclaimer

    Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti

  4. Slide 4: Results Highlights, About Us, Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  5. Slide 5: Q4FY24: Financial Highlights

    Q4FY24 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated 7% 30% -11% 477 106 72 25% 423 99 21% 392 21% 83 55 56 17% 14% 12% Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 Revenue (Rs. Crore) EBITDA (Rs.

  6. Slide 6: FY24: Financial Highlights

    FY24 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -30% -43% -43% 2,371 624 406 26% 21% 1,671 17% 353 232 14% FY23 FY24 FY23 FY24 FY23 FY24 FY23 FY24 Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Standalone

  7. Slide 7: Q4FY24 - Consolidated Performance Highlights

    Q4FY24 - Consolidated Performance Highlights Revenue from Operations for Q4FY24 stood at ₹ 423 crore, as compared to ₹ 392 crore in Q3FY24. Total volumes stood at 27,984 MT for Q4FY24 as against 26,903 MT in Q3FY24. For Q4FY24, • Amines volumes stood at 8,910 MT • Amines Derivatives volumes stood at

  8. Slide 8: Q4FY24 - Consolidated Performance Highlights

    Q4FY24 - Consolidated Performance Highlights • The company is proposing to take up the following projects : o N-Methyl Morpholine (NMM) - 3000 TPA. o N-(n-butyl) Thiophosphoric triamide (NBPT) - 2500 TPA. o Isopropylamine: The company is proposing to manufacture Isopropylamine (Mono & Di) in the exi

  9. Slide 9: Phase-2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV)

    Phase -2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV) EXECUTED ON SCHEDULE IN PROGRESS IN PROGRESS n-Butylamine Methylamines Dimethyl Ether • We plan to undertake capex for a new • Market Leader in Methylamines • Dimethyl Ether (DME) with a Capacity of product, namely n-Butylamine

  10. Slide 10: Standalone Statement of Profit & Loss

    Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q4FY24 Q3FY24 Q-o-Q FY24 FY23 Y-o-Y Total Revenue 373 314 19% 1,359 1,736 -22% Raw Material 190 170 756 1,005 Employee expense 22 18 72 80 Other expenses 66 62 263 311 EBITDA 95 64 48% 267 339 -21% EBITDA Margin 25% 20% 20% 20% Depreci

  11. Slide 11: Standalone Balance Sheet Statement

    Standalone Balance Sheet Statement ASSETS (in Rs. Crore) Mar-24 Mar-23 EQUITY AND LIABILITIES (in Rs. Crore) Mar-24 Mar-23 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 719 599 (a) Equity Share capital 6 6 (b) Capital work-in-progress 141 74 (b) Other equity 1,528 1,394 (c) Intangibl

  12. Slide 12: Standalone Cash Flow Statement

    Standalone Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Mar-24 Mar-23 Profit before Tax 232 305 Adjustment for Non-Operating Items -22 -30 Operating Profit before Working Capital Changes 253 335 Changes in Working Capital -34 -100 Cash Generated from Operations 219

  13. Slide 13: Consolidated Statement of Profit & Loss

    Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q4FY24 Q3FY24 Y-o-Y FY24 FY23 Y-o-Y Total Revenue 423 392 8% 1,671 2,371 -30% Raw Material 213 212 903 1,246 Employee expense 25 21 82 85 Other expenses 79 77 332 415 EBITDA 106 83 29% 353 624 -43% EBITDA Margin 25% 21% 21% 26% Depre

  14. Slide 14: Consolidated Balance Sheet Statement

    Consolidated Balance Sheet Statement ASSETS (in Rs. Crore) Mar-24 Mar-23 EQUITY AND LIABILITIES (in Rs. Crore) Mar-24 Mar-23 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 891 775 (a) Equity Share capital 6 6 (b) Capital work-in-progress 203 113 (b) Other equity 1,715 1,548 Non-contro

  15. Slide 15: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Mar-24 Mar-23 Profit before Tax 302 567 Adjustment for Non-Operating Items -30 -53 Operating Profit before Working Capital Changes 332 620 Changes in Working Capital -49 -147 Cash Generated from Operations 28

  16. Slide 16: Results Highlights, About Us, Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  17. Slide 17: Amines Industry – Unique but Critical Industry with growth potential

    Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally The consumable nature of demand and the is $4.9 billion. Globally, the Amine industry is oligopolistic nature of the industry, results in oligopolistic with two-three producers a stron

  18. Slide 18: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India

    Balaji Amines Ltd – A Leading player in Aliphatic Amines in India State-of-the-art Forward integrated manufacturing suite of products Largest manufacturer of Aliphatic Amines in facilities fully equipped with latest DCS 30+ Product Downstream products added based on strength of amine manufacturing w

  19. Slide 19: Our Products are supplied to India's fast-growing Industries

    Our Products are supplied to India’s fast-growing Industries Industry Wise - Revenue Breakup 3% 4% 3% 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others 18

  20. Slide 20: Highly Experienced Management Team

    Highly Experienced Management Team Mr. A. Prathap Reddy Mr. D. Ram Reddy Mr. N. Rajeshwar Reddy Mr. A. Srinivas Reddy Executive Chairman Managing Director Whole Time Director Whole Time Director & CFO • Civil Engineer by Education. • 37 years of experience across • B. Com. Over 47 years of • Post Gr

  21. Slide 21: Diversified Product Portfolio

    Diversified Product Portfolio Particulars Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing • Amine Derivatives are used to make further consumption and applications in a salts and other complex chemical Intermediates and API’s • Albeit a small and fast growing

  22. Slide 22: Clientele

    Clientele Amines Amine Derivatives Specialty & Other Chemicals 21

  23. Slide 23: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Focus towards high-value derivatives and Develop new indigenous technology for specialty chemicals with an aim to move up manufacturing products leading to lowering in the value-chain with vertical integration manufacturing costs & improving

  24. Slide 24: Key Products (Current & Proposed) in Portfolio

    Key Products (Current & Proposed) in Portfolio Existing Installed Project under Product Proposed Capacity Application Areas Capacity discussion capacity N-Methyl Morpholine (NMM) 3000 TPA Pharma , Oil & Gas N-(n-butyl) Thiophosphoric triamide (NBPT) 2500 TPA Agro Methyl Amine 48,000 40,000 Pharma, A

  25. Slide 25: We are Global suppliers – a significant validation of our Capabilities

    We are Global suppliers – a significant validation of our Capabilities • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatem

  26. Slide 26: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities ISO Certificate Two Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP 02.05.2023 ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP

  27. Slide 27: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities Product Innovator of the Year Distinguished Contribution in the Excellent CSR in Water Mahatma Award for Sustainable and in Chemicals – 2018 Indian Chemicals Industry Conservation Responsible Business Practice from Aditya Birla Group 1st Octobe

  28. Slide 28: We are Growing…Sustainably and Consistently

    We are Growing…Sustainably and Consistently India Ratings Affirms Balaji Amines’ Bank Facilities at ‘IND AA’ “Latest Rating is Non- fund based Facilities INR 1500 Million IND A1+ ; Fund Based Working Capital Facilities INR 1450 Million IND AA / Stable / IND A1+ • Largest manufacturer of aliphatic am

  29. Slide 29: High entry barrier Business – Paving way for Sustainable growth

    High entry barrier Business – Paving way for Sustainable growth Complex manufacturing process Niche product offering with high High fixed costs, with fixed asset requiring high levels of lead time in customer approvals turns hovering in the range of 1.5- technological know-how. Efficient 2x. Optimum

  30. Slide 30: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty chemicals will materialize into higher 01 Solvents account for 80%-90% of the mass utilised in a typical pharmaceutical chemical 05 rev

  31. Slide 31: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility Strategically Project Accorded Project Capex Product Profile Balaji Specialty Located Plant Mega Project Status Chemicals Environmental In Phase-1 of Greenfield The 20 MW Electronic Grade DMC : To Maharashtra’s Energy clearance received Pr

  32. Slide 32: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility New Products = First High Demand for Hotel Expansion Solar Power Plant Mover advantage Products Significant The demand of Planning to add 40 The 20 MW Greenfield opportunity exists to Methylamines has new rooms which introduce new Solar Po

  33. Slide 33: Balaji Speciality Chemicals – Production commenced in FY20

    Balaji Speciality Chemicals – Production commenced in FY20 Balaji Speciality Chemicals Limited (BSCL) is Manufacturing products such as Ethylene Diamine 01 (EDA), Piperazine Anhydrous (PIP) , Di Ethylene Tri 04 BAL owns 55% in subsidiary Balaji Speciality Amine (DETA), Amino Ethyl Ethanol Amines (AE

  34. Slide 34: R&D led Investments to provide significant early mover advantage

    R&D led Investments to provide significant early mover advantage New Products Optimization Integration Continuous efforts to optimize Backward and forward Identification of new products utilization of energy, utilities & integration of products to and development of latest raw materials consumption

  35. Slide 35: Results Highlights, About Us, Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  36. Slide 36: Balaji Sarovar Premiere – Best in class Business Hotel in Solapur

    Balaji Sarovar Premiere – Best in class Business Hotel in Solapur • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Ho

  37. Slide 37: Balaji Sarovar Premiere – Q4 & FY24 Operating Matrix

    Balaji Sarovar Premiere – Q4 & FY24 Operating Matrix Constitutes 129 Rooms 2.21% of Negligible Routine Capex incurred Rs. 4,417 ARR Total Revenue 71% RS. 3,150 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ARR : Average Room Revenue RevPAR: Revenue per Available Room 36

  38. Slide 38: Results Highlights, About Us, Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  39. Slide 39: Consolidated Performance Highlights

    Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 379 353 244 232 941 186 97 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31.8%

  40. Slide 40: Strong Core ROCE Profile

    Strong Core ROCE Profile Particulars (Rs. Crs.) FY23 FY24 Consolidated Debt 58 20 Consolidated Networth 1698 1893  For FY22, investments made to the tune of Rs. 145.54 crore for Unit Total Capital Employed 1756 1913 4’s DMC plant and Unit 3’s power plant is not considered, as the operations were wo

  41. Slide 41: Consistent Dividend Payout

    Consistent Dividend Payout 550% 500% 300% 200% 140% 160% FY19 FY20 FY21 FY22 FY23 FY24 Particulars (Rs. per share) FY19 FY20 FY21 FY22 FY23 FY24 Consolidated Book Value 183 206 281 406 524 584 Consolidated EPS 36 32 74 114 100 63 Dividend 2.80 3.20 4.00 6.00 10.00 11.00 40

  42. Slide 42: Results Highlights, About Us, Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  43. Slide 43: Balaji Amines Ltd - Progressing steadily

    Balaji Amines Ltd - Progressing steadily Unit 4: Increased capacity Improvements at Greenfield Unit 4 : utilization & capacity Subsidiary Plant Capex Phase – 2 & 3 additions of Phase – 1 capex Expansion and commercialization of 90-acre project in MIDC Chincholi to Debottlenecking of the plant for Ca

  44. Slide 44: ESG & CSR Initiatives

    ESG & CSR Initiatives Donation Of Rs Distribution Of 1.25 Crores For RO Plant To Renovation Of Ganesh Naik Punyashlok Primary Ahilyadevi Holkar School, Prasuti Gruh Solapur Solapur (Maternity Dt. 03.01.2023 Hospital) Dt. 08.02.2023 Constructed 2 Construction of Class Room At Class Rooms at Lokseva N

  45. Slide 45: ESG & CSR Initiatives

    ESG & CSR Initiatives Constructed 2 Donation Rs. 2 Cr. Class Room At For Child Saraswati Education, Vidyalay, Women Tamalwadi Dt. Empowerment, Feed To Needy People, Old Age Home, Gau-shala & Drug Free Nation Of Karmaputra Charitable Trust Constructed Constructed Ladies And Gents Kitchen Shed Toilet

  46. Slide 46: ESG & CSR Initiatives

    ESG & CSR Initiatives Distribution Of Distribution Of Flour Mill (Atta Oxygen Chakki) To Concentrator 12 Women’s Nos To Taluka Organisation Arogya Adhikari Dt. 12.08.2022 Tuljapur Dt 22.06.2022 Distribution Of Computer - 2 Nos To Distribution Of School Benches To Zilla Parishad Funded for Polytechni

  47. Slide 47: Thank You

    Thank You For further information, please contact: Company : Investor Relations Advisors : Orient Capital (a division of Link Group) Mr. Bhavya Shah Balaji Amines Ltd. +91 8082748577 CIN - L24132MH1988PLC049387 bhavya.shah@linkintime.co.in Email - cs@balajiamines.com Mr. Rajesh Agrawal +91 99674 914

Balaji Amines — Q4 FY2024 Earnings Presentation on 6ix